![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
1. Carbinoxamine
2. Histex Ct
3. Histex I-e
4. Histex Pd
1. 3505-38-2
2. Carbinoxamine Maleate Salt
3. Lergefin
4. Clistin
5. Ciberon
6. Cliston
7. P-carbinoxamine Maleate
8. Allergefon Maleate
9. Paracarbinoxamine Maleate
10. Nsc-62362
11. Chebi:31353
12. 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine Maleate
13. Ethanamine, 2-((4-chlorophenyl)-2-pyridinylmethoxy)-n,n-dimethyl-, (z)-2-butenedioate (1:1)
14. 02o55696wh
15. 3505-38-2 (carbinoxamine Maleate)
16. Hislosine
17. Ziriton
18. Histine Sirup
19. Polistin T-caps
20. 2-((4-chlorophenyl)(pyridin-2-yl)methoxy)-n,n-dimethylethan-1-amine Maleate
21. Polistine T-caps
22. Dsstox_cid_27805
23. Dsstox_rid_82573
24. Dsstox_gsid_47828
25. Carbinoxamine Hydrogen Maleate
26. Arbinoxa
27. {2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]ethyl}dimethylamine Maleate
28. Clistine Maleate
29. Clistin-d
30. Karbinal Er
31. (z)-but-2-enedioic Acid;2-[(4-chlorophenyl)-pyridin-2-ylmethoxy]-n,n-dimethylethanamine
32. Ethanamine, 2-((4-chlorophenyl)-2-pyridinylmethoxy)-n,n-dimethyl-, (2z)-2-butenedioate (1:1)
33. Ethanamine, 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-n,n-dimethyl-, (2z)-2-butenedioate (1:1)
34. Component Of Clistin-d
35. Sr-01000736676
36. Ncgc00166141-01
37. Einecs 222-498-0
38. Nsc 62362
39. Clistin Maleate
40. Unii-02o55696wh
41. Carbinoxamine Maleate [usp:jan]
42. Prestwick_238
43. Arbinoxamine Maleate
44. Clistin (tn)
45. Karbinal Er (tn)
46. 2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]-n,n-dimethylethanamine Maleate
47. Carbinoxamine (maleate)
48. Carbinoxaminemaleate
49. 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine Bimaleate
50. 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine Maleate (1:1)
51. Cas-3505-38-2
52. Schembl97703
53. Spectrum1500161
54. Chembl1200974
55. Dtxsid0047828
56. Hms502i21
57. Hy-b1589a
58. Carbinoxamine Maleate (jan/usp)
59. Carbinoxamine Maleate [mi]
60. Hms1570b03
61. Hms1920i21
62. Hms2091a04
63. Hms2097b03
64. Hms3259g22
65. Hms3714b03
66. Hms3885f18
67. Pharmakon1600-01500161
68. Carbinoxamine Maleate [jan]
69. Bcp28449
70. Nsc62362
71. Tox21_112336
72. Carbinoxamine Maleate [vandf]
73. Ccg-40113
74. Mfcd00050923
75. Nsc756670
76. S4696
77. Carbinoxamine Maleate [mart.]
78. Wln: Qv1u1vq -c &621
79. Akos015962162
80. Carbinoxamine Maleate [usp-rs]
81. Carbinoxamine Maleate [who-dd]
82. Tox21_112336_1
83. Ac-5508
84. Cs-8018
85. Nc00602
86. Nsc-756670
87. Ethanamine, 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-n,n-dimethyl-,(2z)-2-butenedioate (1:1)
88. Pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)-, Maleate (1:1)
89. Ncgc00095302-01
90. Ncgc00166141-06
91. Bs-43784
92. Carbinoxamine Maleate [orange Book]
93. Carbinoxamine Maleate [usp Monograph]
94. Carbinoxamine Maleate Salt, Analytical Standard
95. D01336
96. Ethanamine,n-dimethyl-, (z)-2-butenedioate (1:1)
97. Sr-01000736676-2
98. Sr-01000736676-3
99. Q27114280
100. 2-[p-chloro-.alpha.-[2-(dimethylamino)ethoxy]benzyl]pyridine Bimaleate
101. 2-[p-chloro-.alpha.-[2-(dimethylamino)ethoxy]benzyl]pyridine Maleate
102. Carbinoxamine Maleate, United States Pharmacopeia (usp) Reference Standard
103. 2-(p-chloro-.alpha.-(2-(dimethylamino)ethoxy)benzyl)pyridine Maleate (1:1)
104. 2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]-n,n-dimethylethanamine (2z)-but-2-enedioate
Molecular Weight | 406.9 g/mol |
---|---|
Molecular Formula | C20H23ClN2O5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 8 |
Exact Mass | 406.1295495 g/mol |
Monoisotopic Mass | 406.1295495 g/mol |
Topological Polar Surface Area | 100 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 386 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Carbinoxamine maleate |
Drug Label | Carbinoxamine maleate is a histamine-H1 receptor blocking agent.Each 5 mL (teaspoonful) of oral solution contains 4 mg carbinoxamine maleate and the following inactive ingredients: artificial bubble gum flavor, citric acid (anhydrous), glycerin, meth... |
Active Ingredient | Carbinoxamine maleate |
Dosage Form | Tablet; Solution |
Route | oral; Oral |
Strength | 4mg; 4mg/5ml |
Market Status | Prescription |
Company | Vintage Pharms; Cypress Pharm; Lynrose Labs; Mikart; Invagen Pharms |
2 of 4 | |
---|---|
Drug Name | Karbinal er |
PubMed Health | Carbinoxamine (By mouth) |
Drug Classes | Cold/Cough Agent, Respiratory Agent |
Drug Label | Each 5 mL of Karbinal ER Extended-release Oral Suspension contains carbinoxamine complexed with polistirex equivalent to 4 mg carbinoxamine maleate and the following inactive ingredients: citric acid anhydrous, strawberry-banana flavor, glycerin, hig... |
Active Ingredient | Carbinoxamine maleate |
Dosage Form | Suspension, extended release |
Route | Oral |
Strength | 4mg/5ml |
Market Status | Prescription |
Company | Tris Pharma |
3 of 4 | |
---|---|
Drug Name | Carbinoxamine maleate |
Drug Label | Carbinoxamine maleate is a histamine-H1 receptor blocking agent.Each 5 mL (teaspoonful) of oral solution contains 4 mg carbinoxamine maleate and the following inactive ingredients: artificial bubble gum flavor, citric acid (anhydrous), glycerin, meth... |
Active Ingredient | Carbinoxamine maleate |
Dosage Form | Tablet; Solution |
Route | oral; Oral |
Strength | 4mg; 4mg/5ml |
Market Status | Prescription |
Company | Vintage Pharms; Cypress Pharm; Lynrose Labs; Mikart; Invagen Pharms |
4 of 4 | |
---|---|
Drug Name | Karbinal er |
PubMed Health | Carbinoxamine (By mouth) |
Drug Classes | Cold/Cough Agent, Respiratory Agent |
Drug Label | Each 5 mL of Karbinal ER Extended-release Oral Suspension contains carbinoxamine complexed with polistirex equivalent to 4 mg carbinoxamine maleate and the following inactive ingredients: citric acid anhydrous, strawberry-banana flavor, glycerin, hig... |
Active Ingredient | Carbinoxamine maleate |
Dosage Form | Suspension, extended release |
Route | Oral |
Strength | 4mg/5ml |
Market Status | Prescription |
Company | Tris Pharma |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)